Xolair 150 MG/1.2 ML powder VLS
Ended Awarded Last action
- Contract number
- SPE2DR26FCFM3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,265
Award facts
- Contract value 100% obligated
- $10,264.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,264.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 MG/1.2 ML powder vials. This firm fixed-price delivery order, issued on December 16, 2025, with an ultimate completion date of January 8, 2026, was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The order will be fulfilled at DMS Pharmaceutical Group's place of performance in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That parent IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier supporting Department of Defense healthcare operations. The PPV-G GEN V program represents part of a broader $30.3 billion government acquisition strategy designed to provide a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide through multiple prime vendor contractors.
Quick answers
Who was awarded contract SPE2DR26FCFM3?
SPE2DR26FCFM3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FCFM3 worth?
The government has obligated $10,265 on SPE2DR26FCFM3.
Is contract SPE2DR26FCFM3 an order under another contract?
Yes. SPE2DR26FCFM3 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFM3 competed?
The extent of competition for SPE2DR26FCFM3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award